# Immunotherapy
Latest news and articles about Immunotherapy
Total: 2 articles found
Bispecific Ambition: Akeso’s Ivonescimab Challenges the Oncology Hierarchy in Chicago
Akeso Biopharma’s ivonescimab has demonstrated a significant survival advantage over traditional PD-1 therapies in a landmark Phase III lung cancer trial. While the results signal a shift toward bispecific antibodies as the new standard, experts caution that further global data and longer follow-up are needed to solidify its dominance.
mRNA’s New Frontier: MIT Breakthrough Signals an End to ‘Untreatable’ Solid Tumors
Researchers from MIT and MGH have developed a groundbreaking mRNA-based adjuvant that cleared solid tumors in aggressive animal models. By reprogramming dendritic cells to enhance T-cell responses, the study published in Nature Biotechnology offers a potential breakthrough for treating 'cold' tumors that are currently resistant to standard immunotherapy.